Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in CYTK — Cytokinetics Inc

CIK 923093 STAMFORD, CT

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,895,409
+$7,895,409 QoQ
Shares Held
92,680
Ownership
0.067%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#137
of 477 holders
Holding Since
Mar 2021
13 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in CYTK Over Time

Shares Held

Position Value (USD)

Derivatives in CYTK

reported options exposure · as of Jun 30, 2026
CallValue
$11,279,156
CallShares
132,400
PutValue
$1,899,737
PutShares
22,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. CYTK ranks #11 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CYTK

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,895,409 92,680
2026-06-30 $1,899,737 22,300
2026-06-30 $11,279,156 132,400
2026-03-31 $474,552 7,200
2026-03-31 $817,284 12,400
2025-12-31 $794,250 12,500
2025-12-31 $292,284 4,600
2025-09-30 $258,312 4,700
2024-06-30 $4,062,904 74,989
2024-03-31 $5,309,850 75,736
2024-03-31 $869,364 12,400
2024-03-31 $680,067 9,700
2023-12-31 $609,477 7,300
2023-12-31 $2,982,847 35,727
2023-03-31 $1,134,560 32,241
2022-12-31 $841,392 18,363
2022-09-30 $3,093,920 63,858
2022-06-30 $1,206,360 30,704
2021-06-30 $481,233 24,317
2021-03-31 $1,065,121 45,792